Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 15,165	$ 11,231
Accounts receivable, net of allowance for doubtful accounts of $2,115 and $3,013, respectively	9,418	15,958
Inventory	11,038	18,515
Prepaid expenses and other current assets	1,905	5,558
Total current assets	37,526	51,262
Property and equipment, net	496	1,108
Right of use assets, net	1,290	2,260
Intangible assets, net	2,219	2,279
Other assets	755	1,195
Total assets	42,286	58,104
Current liabilities:
Accounts payable	18,365	30,432
Accrued and other expenses	10,132	19,984
Current portion of deferred revenues	908	1,148
Line of credit	4,933	4,685
Current portion of long-term debt	6,764	10,353
Total current liabilities	41,102	66,602
Long-term debt, net	500	0
Noncurrent lease liabilities	72	1,162
Common stock warrant liabilities	24,178	724
Other long-term liabilities	1,474	251
Total liabilities	67,326	68,739
Commitments and Contingencies
Stockholders’ equity (deficit):
Common stock, $0.0001 par value, 107,142,857 shares authorized as of September 30, 2023 and December 31, 2022; 8,563,301 and 8,242,009 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively.	1	1
Additional paid-in capital	216,780	212,122
Accumulated deficit	(248,733)	(222,758)
Total stockholders’ deficit	(31,952)	(10,635)
Total liabilities, convertible preferred stock, and stockholders’ deficit	42,286	58,104
Series A Convertible Preferred Stock
Current liabilities:
Series A convertible preferred stock, $0.0001 par value, 10,741,071 shares authorized as of September 30, 2023 and December 31, 2022; 30,000 and 0 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively (liquidation preference of $30,000)	$ 6,912	$ 0